India  

Dr. Reddy's Laboratories

Indian multinational pharmaceutical company

Dr. Reddy's Laboratories    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.

0
shares
ShareTweetSavePostSend
 

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials [Video]

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials

Institute of Nuclear Medicine and Allied Sciences-DRDO scientist Dr Sudhir Chandna on drug 2-deoxy-D-glucose (2-DG) while speaking to ANI informed about the observations of the medicine's clinical..

Credit: ANI     Duration: 01:59Published
Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head [Video]

Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head

Sputnik V is a minus 18-degrees Celsius storage vaccine, informed Ravi Mathur, Global Logistics' Head, Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01."Sputnik V is a..

Credit: ANI     Duration: 01:43Published
Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO [Video]

Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO

The Sputnik V vaccine will be available in a few weeks after statutory clearances, informed Deepak Sapra, CEO of Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01. "Today,..

Credit: ANI     Duration: 01:02Published
150,000 doses of Sputnik V have arrived in India on 1st May | Oneindia News [Video]

150,000 doses of Sputnik V have arrived in India on 1st May | Oneindia News

Sputnik V is the Russian made covid vaccine with an efficacy rate above 90%. 150,000 doses of Sputnik have arrived at Hyderabad in India on Saturday. The vaccines will be handed over to Dr Reddy's..

Credit: Oneindia     Duration: 01:01Published

You Might Like


Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency use

A potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) – has received the Drugs Controller General of India (DCGI) nod for emergency use as adjunct therapy for..
IndiaTimes - Published

Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine

Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations...
IndiaTimes - Published

Expert panel seeks additional data from Dr Reddy's Laboratories on Russian Covid vaccine Sputnik V


IndiaTimes - Published

Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine..
IndiaTimes - Published

Sputnik V India rollout in emergency use authorisation mode expected in March

The Russian Covid-19 vaccine Sputnik V is expected to be rolled out into the Indian market in March this year in EUA (emergency use authorisation) mode, a top official of Dr Reddy’s Laboratories said..
IndiaTimes - Published

All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretary

Swarup said Dr Reddy's Laboratories has partnered with Russia's Gamaleya Institute and a vaccine is being developed for India targeting storage at 2-8 degrees Celsius. The country's drugs regulator..
IndiaTimes - Published

Russia will jointly produce Sputnik V vaccine with India: Envoy

Russian envoy in New Delhi Nikolay Kudashev on Monday said Moscow will jointly produce the Sputnik V vaccine for Covid-19 along with India and it will be manufactured by Indian pharma major Dr Reddy's..
IndiaTimes - Published

Dr Reddy's, RDIF begin clinical trials for Russia's Sputnik V vaccine in India

Dr Reddy's and RDIF had entered into a partnership to conduct clinical trials and rights for distribution of the first 100 million doses in India.
DNA - Published

India trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy's

The company expects to enrol 100 participants for the mid-stage trial and 1,500 people for the late-stage.
DNA - Published Also reported by •IndiaTimes

Russian Sputnik V Covid-19 vaccine to be tested on 100 Indian volunteers

The Russian Sputnik V vaccine against Covid-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on..
IndiaTimes - Published

Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India

After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian Covid-19 vaccine Sputnik V, the company..
IndiaTimes - Published

India declines proposal to test Sputnik-V Covid-19 vaccine in large study

India's drug regulator has knocked back a proposal from Dr Reddy's Laboratories Ltd to conduct a large study in the country to evaluate Russia's Sputnik-V Covid-19 vaccine and has asked it to first..
IndiaTimes - Published

COVID-19 vaccine to be available in India by early 2021: Union Health Minister Harsh Vardhan

Meanwhile, Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of the world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's Laboratories as Moscow speeds..
DNA - Published

Russia, Dr Reddy’s tie up for Sputnik V trial

Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on clinical trials and distribution of..
IndiaTimes - Published

Russia confirms deal with Dr. Reddy's for COVID-19 vaccine 'Sputnik V' trials in India, to supply 100 million doses

Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's Laboratories as Moscow speeds up plans to..
DNA - Published

Russia to sell 100 million doses of Covid-19 vaccine to India

Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19 once it receives regulatory approval...
IndiaTimes - Published